Evidence map›Paper›PMID 36393872›Full record

ArticleCurrent research in toxicology2022

Developmental deltamethrin: Sex-specific hippocampal effects in Sprague Dawley rats.

Emily M Pitzer, Chiho Sugimoto, Samantha L Regan, Gary A Gudelsky, Michael T Williams, Charles V Vorhees

Open access · goldAbstract read
In one paragraph

Article in Current research in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Emily M PitzerDept. of Pediatrics, University of Cincinnati College of Medicine, and Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Chiho SugimotoDept. of Physiology, Michigan State University, 766 Service Rd. 5401 Interdisciplinary Science and Technology Building, East Lansing, MI 48824, USA.
Samantha L ReganDept. of Human Genetics, University of Michigan Medical Center, 3703 Med Sci II, 1241 E. Catherine St., Ann Arbor, MI 48109-5618, USA.
Gary A GudelskyCollege of Pharmacy, Div. of Pharmaceutical Sciences, 3212 Medical Sciences Building, University of Cincinnati, Cincinnati, OH 45219, USA.
Michael T WilliamsDept. of Pediatrics, University of Cincinnati College of Medicine, and Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Charles V VorheesDept. of Pediatrics, University of Cincinnati College of Medicine, and Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USMichigan State University · USUniversity of Michigan–Ann Arbor · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
Integrative Pharmacological Sciences Training Program (IPSTP)T32GM142521 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ANNE M. DORRANCE, Gina Marie Leinninger · 2021 to 2026
$2.4M
Gene-pesticide interactions and ADHDR01ES032270 · NIEHS · CINCINNATI CHILDRENS HOSP MED CTR · PI VORHEES, CHARLES V, WILLIAMS, MICHAEL T · 2020 to 2024
$2.2M
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS R01 ES032270NIGMS NIH HHS T32 GM142521
6 · The paper itself

Abstract

Pyrethroid pesticides are widely used and can cause long-term effects after early exposure. Epidemiological and animal studies reveal associations between pyrethroid exposure and altered cognition following prenatal and/or neonatal exposure. However, little is known about the cellular effects of such exposure. Sprague Dawley rats were gavaged with 0 or 1.0 mg/kg deltamethrin (DLM), a Type II pyrethroid, in corn oil (dose volume 5 mL/kg) once per day from postnatal day (P) 3-20 and assessed shortly after dosing ended or as adults. No effects of DLM exposure were found on striatal dopaminergic markers, nor on AMPA receptor subunits or on NMDA-NR1. However, DLM increased NMDA-NR2A and decreased NMDA-NR2B levels in the hippocampus, in males but not females. Additionally, adult hippocampal CA1 long-term potentiation was increased in DLM-treated males but not females. Potassium stimulated extracellular glutamate release in the hippocampus was not affected using

Indexed as

ApoptosisCaspase-3CytokinesDA, dopamineDeltamethrinDLM, deltamethrinDopamineGlutamateLong-term potentiationLTP, Long-term potentiationPyrethroidsRats

Identifiers

PMID36393872
PMCPMC9661443
OpenAlexW4308829926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.